Drug Addiction in Canada:
A Growing Public Health Concern
Substance use continues to affect individuals, families, and communities across Canada.
According to data from the Government of Canada, more than 30,000 Canadians died from opioid toxicity between January 2016 and September 2022, reflecting the increasing complexity and severity of the country’s substance use crisis.
During the same period, healthcare systems across Canada reported rising rates of emergency department visits, hospitalizations, and mental health concerns associated with alcohol, opioids, stimulants, and polysubstance use.
The Impact of Substance Use
The impacts of substance use extend beyond overdose deaths alone. Communities across the country continue to experience increased pressure on healthcare services, social systems, housing supports, child welfare services, and law enforcement. While public awareness surrounding addiction has grown in recent years, access to treatment, rehabilitation, and long-term recovery support remains uneven across many regions of Canada.
On October 5, 2022, the federal government announced additional measures related to the opioid crisis and substance use policy, including expanded harm reduction initiatives and support for treatment access.
Public discussion surrounding decriminalization, prevention, rehabilitation, and recovery continue to evolve as Canada responds to ongoing changes in the unregulated drug supply.
Changes in Canada’s Drug Supply
Since the COVID-19 pandemic, health authorities and toxicology reports have identified significant changes in the unregulated drug supply across Canada. Substances such as fentanyl, cocaine, crack cocaine, methamphetamine, and amphetamine continue to appear frequently in drug seizure and urinalysis data.
Fentanyl and Other Substances
Fentanyl and fentanyl analogues remain major contributors to overdose deaths in several provinces, particularly in western Canada. Health agencies have also reported increasing detection of unregulated benzodiazepines mixed with opioids and stimulants.
These combinations can increase overdose risk and complicate emergency medical responses. The modern substance use landscape in Canada has become increasingly unpredictable. Individuals may consume substances without knowing their exact contents or potency. This unpredictability contributes to higher risks of poisoning, overdose, and long-term health complications.
Substance Use Statistics in Canada
Substance use patterns vary across age groups, regions, and socioeconomic backgrounds. However, national surveys continue to identify several ongoing trends.
Alcohol Use
Alcohol remains the most used psychoactive substance in Canada. While legal and socially normalized, alcohol misuse contributes to significant health and social harms, including impaired driving, chronic disease, injury, violence, and mental health concerns.
Risky alcohol use remains highest among young adults between the ages of 18 and 24. Public health researchers have also observed increased alcohol consumption among some adult populations since the pandemic, particularly during periods of social isolation and economic stress.
Prescription Stimulant Use
The use of prescription stimulants has increased in Canada since 2015, particularly among youth and postsecondary students. Surveys suggest that non-medical use of stimulants is often associated with academic pressure, performance enhancement, and recreational use.
Among Canadians aged 17 to 25 who reported using prescription stimulants, a substantial proportion described patterns consistent with problematic use. Misuse of prescription stimulants may increase the risk of dependency, cardiovascular complications, anxiety, and sleep disturbances.
Opioid Use
Opioid medications continue to play a role in pain management within Canadian healthcare settings. However, opioid misuse remains a significant public health concern.
National data indicates that approximately 12% of Canadians report using opioid pain medication, while a smaller percentage report non-medical use. Between January 2016 and September 2025, Canada recorded 55,032 apparent opioid-related deaths.
Canada’s Opioid Crisis
Since national surveillance began in 2016, Canada has faced a surge in toxic drug poisonings—a crisis that peaked during the COVID-19 pandemic. While recent data shows a welcome shift back toward pre-pandemic levels, the human toll remains staggering.
As of 2024, accidental poisonings continue to be the leading cause of death for Canadian men aged 20–49 and women aged 20–39.
Canada’s opioid crisis remains one of the most serious public health emergencies in recent decades. Opioids such as fentanyl have contributed to substantial increases in overdose deaths across multiple provinces.
Several factors continue to influence the crisis, including:
- the presence of fentanyl within the unregulated drug supply
- polysubstance use involving opioids and stimulants
- mental health challenges and trauma
- barriers to treatment access
- housing instability and poverty
- regional differences in healthcare availability
Many opioid-related poisonings occur accidentally, often involving substances contaminated with fentanyl or other synthetic opioids. Young adults between the ages of 15 and 24 remain one of the fastest-growing groups requiring hospital treatment related to opioid poisoning.
Public health responses across Canada now include a combination of prevention, harm reduction, detoxification services, residential treatment, outpatient care, and long-term recovery support.
Youth and Young Adults
Remain at Higher Risk
Rates of substance use continue to be highest among youth and young adults. Early exposure to drugs and alcohol may increase the likelihood of developing long-term substance use disorders later in life.
Cannabis remains one of the most used substances among Canadian youth. Canada has historically reported some of the highest youth cannabis use rates among developed countries. Researchers have also observed earlier initiation of cannabis use among certain populations.
Additional concerns include:
- higher rates of illicit drug use among youth and young adults
- increased rates of prescription drug misuse
- elevated risks among vulnerable and street-involved youth populations
- co-occurring mental health challenges such as anxiety, depression, and trauma-related conditions
Early intervention, family support, education, and access to evidence-informed treatment services may improve long-term outcomes for young people experiencing substance-related harms.
Prevention, Treatment, and Rehabilitation
Prevention and education continue to play important roles in reducing substance-related harm in Canada. Public education campaigns, school-based prevention programs, and community outreach initiatives may help increase awareness surrounding substance use risks and early intervention strategies. At the same time, prevention alone does not eliminate the need for treatment and rehabilitation services.
Many Canadians continue to experience barriers when seeking help, including:
- long wait times for publicly funded treatment
- limited availability of specialized programs
- geographic barriers in rural and northern communities
- stigma associated with addiction and mental health conditions
Treatment approaches may include detoxification services, inpatient rehabilitation, outpatient counselling, trauma-informed care, medication-assisted treatment, peer support, and community aftercare services.
Stigma and Social Impact
Stigma surrounding addiction remains a significant issue in Canada. Individuals affected by substance use disorders may experience discrimination in healthcare, employment, housing, and social settings. Stigma can discourage people from seeking treatment or disclosing substance-related concerns early.
Substance use also carries broader social and economic impacts. Healthcare costs, lost productivity, criminal justice involvement, homelessness, and family disruption contribute substantial financial strain on communities and public systems each year.
Public Awareness and Understanding
Public understanding of addiction has gradually shifted in recent years. Increasingly, substance use disorders are being discussed within a health and public policy framework rather than solely through criminal or moral perspectives. However, significant challenges remain in balancing prevention, treatment, recovery support, and public safety responses.
Addressing substance use in Canada requires coordinated efforts involving healthcare providers, educators, policymakers, families, and community organizations. Long-term solutions continue to depend on accessible treatment, evidence-informed prevention, recovery support services, and ongoing public education.
If you or someone you love is struggling with addiction, free and confidential support is available every day. We can help you determine and take the next step.
